Statistics
Publications
2
Citations
57
H-Index
2
Active since
2022
Affiliations
Bristol-Myers Squibb (Sweden)(Current)
Daniel van Kalken is an author at Bristol-Myers Squibb (Sweden) specializing in cytokine inhibition, kinase inhibitors, and mapk signaling.
Publications per year
2022–2024
2
2
1–2 of 2